Due to the lack of effective treatments, advanced colorectal cancer (CRC) remains a leading cause of cancer death in the United States. Emerging evidence supports the observation that muscarinic receptor (MR) signaling plays a critical role in growth and progression of CRC. MR activation by acetylcholine and bile acids results in transactivation of epidermal growth factor receptors (EGFR) and post-EGFR signal transduction that enhances cell proliferation, migration, and invasion. Here, the authors review recent progress in understanding the molecular mechanisms underlying MR-mediated CRC progression and its therapeutic implications
International audiencelapsing intestinal inflammation that favours the development of colitis associ...
AbstractLithocholic acid (LA) conjugates interact with M3 receptors, the muscarinic receptor subtype...
Despite advances in the diagnosis and treatment of colorectal cancer (CRC), it remains a major cause...
Despite a reduction in incidence over the past decade, colon cancer remains the second most common c...
Muscarinic receptors (CHRM) are overexpressed in colon cancer. To explore a role for muscarinic rece...
Cancers arising from gastrointestinal epithelial cells are common, aggressive, and difficult to trea...
Colorectal cancer (CRC) is the fourth leading cause of the worldwide cancer mortality. Different mol...
Colorectal cancer (CRC) is the fourth leading cause of the worldwide cancer mortality. Different mol...
Colorectal cancer (CRC) ranks among the third most common human malignant diseases and is one of the...
Human colorectal cancer (CRC) is a frequent neoplasia inWestern countries, and its metastatic progre...
Tumor cells have evolved to express immunosuppressive molecules allowing their evasion from the host...
Background: Cancer cells express immunosuppressive molecules, such as programmed death ligands (PD-L...
Cholinergic signaling via the muscarinic M3 acetylcholine receptor (M3R) is involved in the developm...
Colorectal cancer is one of the most common cancers, and diagnosis at late metastatic stages is the ...
Tumor cells have evolved to express immunosuppressive molecules allowing their evasion from the host...
International audiencelapsing intestinal inflammation that favours the development of colitis associ...
AbstractLithocholic acid (LA) conjugates interact with M3 receptors, the muscarinic receptor subtype...
Despite advances in the diagnosis and treatment of colorectal cancer (CRC), it remains a major cause...
Despite a reduction in incidence over the past decade, colon cancer remains the second most common c...
Muscarinic receptors (CHRM) are overexpressed in colon cancer. To explore a role for muscarinic rece...
Cancers arising from gastrointestinal epithelial cells are common, aggressive, and difficult to trea...
Colorectal cancer (CRC) is the fourth leading cause of the worldwide cancer mortality. Different mol...
Colorectal cancer (CRC) is the fourth leading cause of the worldwide cancer mortality. Different mol...
Colorectal cancer (CRC) ranks among the third most common human malignant diseases and is one of the...
Human colorectal cancer (CRC) is a frequent neoplasia inWestern countries, and its metastatic progre...
Tumor cells have evolved to express immunosuppressive molecules allowing their evasion from the host...
Background: Cancer cells express immunosuppressive molecules, such as programmed death ligands (PD-L...
Cholinergic signaling via the muscarinic M3 acetylcholine receptor (M3R) is involved in the developm...
Colorectal cancer is one of the most common cancers, and diagnosis at late metastatic stages is the ...
Tumor cells have evolved to express immunosuppressive molecules allowing their evasion from the host...
International audiencelapsing intestinal inflammation that favours the development of colitis associ...
AbstractLithocholic acid (LA) conjugates interact with M3 receptors, the muscarinic receptor subtype...
Despite advances in the diagnosis and treatment of colorectal cancer (CRC), it remains a major cause...